BAFFR

BAFFR

BAFFR Molekülinformation

Molecule Name
B-cell activating factor receptor
Molekülalias
BAFFR,TNFRSF13C,BROMIX,CD268,CVID4,prolixin,BAFF-R
Drug Development Progress
Anzahl der klinischen Arzneimittel14
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphaseNDA/BLA
Target-Alias
BAFFR,B Cell-Activating Factor Receptor,Prolixin,BROMIX,CD268,Tumor Necrosis Factor Receptor Superfamily, Member 13C,Tumor Necrosis Factor Receptor Superfamily Member 13C,BR3,CVID4,CD268 Antigen,BAFF Receptor,B-Cell Activation Factor Receptor,BAFF-R,TNF Receptor Superfamily Member 13C,BLyS Receptor 3,B-Cell-Activating Factor Receptor,TNFRSF13C
Molekülhintergrund
BAFF receptor (B-cell activating factor receptor, BAFF-R), also known as tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), is a membrane protein of the TNF receptor superfamily which recognizes BAFF. B-cell activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of BAFF in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells.

BAFFR Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Antikörperprojekt-Handelsplattform

ProjektnameProjektphaseMolekültypMolekülquelleKrankheitsgebietIndikationen
BAFFR&CD3 BsAb - 01PCCBispecificHumanized Mouse,NanobodyHematological Malignancy,AutoImmunityBlood tumor,Autoimmune disease
Projektphase
PCC
Molekültyp
Bispecific
Molekülquelle
Humanized Mouse,Nanobody
Krankheitsgebiet
Hematological Malignancy,AutoImmunity
Indikationen
Blood tumor,Autoimmune disease